4//SEC Filing
ANDREWS DEBORAH J 4
Accession 0000950170-24-081602
CIK 0000876343other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:00 PM ET
Size
5.3 KB
Accession
0000950170-24-081602
Insider Transaction Report
Form 4
ANDREWS DEBORAH J
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-07-01+75,000→ 75,000 totalExercise: $0.95Exp: 2034-07-01→ Common Shares (75,000 underlying)
Footnotes (1)
- [F1]Will vest and become exercisable on July 1, 2025, subject to the reporting person's continuous service with the issuer.
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001325697
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:00 PM ET
- Size
- 5.3 KB